➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Dow
Express Scripts
Baxter
Medtronic

Last Updated: June 19, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Apabetalone


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Apabetalone?

Apabetalone is an investigational drug.

There have been 7 clinical trials for Apabetalone. The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2015.

The most common disease conditions in clinical trials are Coronary Disease, Coronary Artery Disease, and Cardiovascular Diseases. The leading clinical trial sponsors are Resverlogix Corp, Steeve Provencher, and PPD.

There are eighty-eight US patents protecting this investigational drug and six hundred and eighty-eight international patents.

Recent Clinical Trials for Apabetalone
TitleSponsorPhase
An Open-Label Study of Apabetalone in Covid InfectionResverlogix CorpPhase 2/Phase 3
Apabetalone for Pulmonary Arterial Hypertension: a Pilot StudySteeve ProvencherEarly Phase 1
Safety and Effect of Oral RVX000222 in Subjects With Fabry DiseaseResverlogix CorpPhase 1/Phase 2

See all Apabetalone clinical trials

Clinical Trial Summary for Apabetalone

Top disease conditions for Apabetalone
Top clinical trial sponsors for Apabetalone

See all Apabetalone clinical trials

US Patents for Apabetalone

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Apabetalone   Get Started Free Pharmaceutical compositions for substituted quinazolinones Resverlogix Corp. (Calgary, Alberta, CA)   Get Started Free
Apabetalone   Get Started Free Pretargeted activatable cell penetrating peptide with intracellularly releasable prodrug The Regents of the University of California (Oakland, CA)   Get Started Free
Apabetalone   Get Started Free Compositions containing HC-HA/PTX3 complexes and methods of use thereof TISSUETECH, INC. (Miami, FL)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Moodys
Johnson and Johnson
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.